Publications by authors named "D I McCormack"
Background: Multiple sclerosis (MS) is a demyelinating autoimmune condition, in which body image may be altered due to a range of biopsychosocial factors. The aim of this review was to examine whether there is a relationship between body image and psychological outcomes in MS, in order to guide clinical intervention development.
Methods: PsycINFO, Medline, CINAHL and Scopus databases were searched systematically in November 2023 for eligible studies, using terms relating to MS and body image.
Background: Medication non-adherence in schizophrenia is a major cause of relapse and hospitalization, presenting a significant challenge for clinicians. This study was conducted to estimate the prevalence of medication non-adherence and identify the impact of depression, as well as other factors, on medication adherence in individuals with schizophrenia.
Methods: This was a cross-sectional study conducted among individuals with schizophrenia, both outpatients and inpatients.
Article Synopsis
- * By employing single-nucleus RNA sequencing, researchers analyzed over 170,000 astrocyte nuclei across different developmental stages and brain areas in mice and marmosets, revealing distinct regional differences in astrocyte gene expression that are not shared with neurons or other glial cells.
- * The study found that while astrocytes show regional patterns even in late embryonic stages, their gene expression changes significantly after birth for specialization, with differences in gene expression and maturation timing observed between the two species studied. *
Background: Although widely accessible digital technology (DT) provided multiple opportunities for young children's play, learning, and development, it also raised parents and professionals' concerns regarding its impact on children's physical activity. This study aimed to identify practices involving DT that were valued by parents in helping their young child to be physically active.
Methods: Participants were parents of ambulatory young children (less than 5 y of age) engaged with a playgroup.
The COVID-19 pandemic was associated with increases in the prevalence of depression and anxiety among children and young adults. We studied whether the pandemic was associated with changes in prescription benzodiazepine use. We conducted a population-based study of benzodiazepine dispensing to children and young adults ≤ 24 years old between January 1, 2013, and June 30, 2022.
View Article and Find Full Text PDF